JADPRO 1 Fig01

Understanding the Role of Targets and Pathways in the Treatment of Non–Small Cell Lung Cancer

A continuing education article for physicians, PAs, doctors of nursing practice, nurse practitioners, advanced practice nurses including clinical nurse specialists, and other advanced degree nurses.

Click here for continuing education information.

After reviewing the articles in this supplement, click on the "How to Earn Credit" link at the bottom of the page for instructions on how to take the learning assessment, complete the evaluation form, and earn credit.

Annenberg Logo

JADPRO Logo

Logo Harborside Meded Color

 

Faculty

Lisa Cordes, PharmD, BCACP, BCOP, National Institutes of Health

Sandra Cuellar, PharmD, BCOP, University of Illinois Hospital and Health Sciences System—Pharmacy Practice

Marianne Davies, DNP, MSN, CNS, ACNP, AOCNP®, Yale University School of Nursing

Beth Eaby-Sandy, MSN, CRNP, OCN®, Abramson Cancer Center, Hospital of the University of Pennsylvania

Clell Hasenbank, PharmD, Providence St Mary Regional Cancer Center

Karen Oishi, MSN, APRN, AGPCNP-BC, OCN®, The University of Texas MD Anderson Cancer Center

Melinda Oliver, BA, BSN, RN, MPAP, The University of Texas MD Anderson Cancer Center

Samantha Schmidt, PharmD, Lexington Medical Center

Helen Shih, MSN, MPH, University of California, San Francisco Department of Thoracic Oncology

Grashma Vadakkel, PharmD(c), University of South Florida College of Pharmacy

Elizabeth S. Waxman, RN, MSN, AOCN®, ANP-BC, The University of Texas MD Anderson Cancer Center


This supplement is supported by educational grants from the following companies: Genentech and Merck Sharp & Dohme Corp.

Save


Editorial

Letter From the Guest Editors



Read More
Editorial

Take a Deep Breath: More Treatment Options for Non–Small Cell Lung Cancer

Lisa Cordes, PharmD, BCACP, BCOP, and Elizabeth S. Waxman, RN, MSN, AOCN®, ANP-BC 

Read More
Review Article

Diagnosis of Lung Cancer

Marianne Davies, DNP, MSN, CNS, ACNP, AOCNP®, and Helen Shih, MSN, MPH

Read More
Review Article

Fundamentals of Lung Cancer Staging

Marianne Davies, DNP, MSN, CNS, ACNP, AOCNP®

Read More
Review Article

Predictive and Prognostic Biomarkers and Related Therapies in Non–Small Cell Lung Cancer

Samantha Schmidt, PharmD, and Grashma Vadakkel, PharmD(c)

Read More
Review Article

Supportive Care and Management of Treatment-Emergent Adverse Events With Targeted Therapy in Non–Small Cell Lung Cancer

Clell Hasenbank, PharmD

Read More
Review Article

Emerging Biomarkers in Non–Small Cell Lung Cancer

Melinda Oliver, BA, BSN, RN, MPAP

Read More
Review Article

Immunotherapy Mechanisms of Action in Non–Small Cell Lung Cancer

Beth Eaby-Sandy, MSN, CRNP, OCN®

Read More
Review Article

Unleashing the Immune System With Checkpoint Inhibitors in Non–Small Cell Lung Cancer: Clinical Review of Adverse Events

Sandra Cuellar, PharmD, BCOP

Read More
Review Article

Emerging Therapies in Non–Small Cell Lung Cancer: Clinical Trials With Novel Agents 

Karen Oishi, MSN, APRN, AGPCNP-BC, OCN®

Read More
Tools and Technology

Resources for Patients With Non–Small Cell Lung Cancer and Their Caregivers and Providers

Elizabeth S. Waxman, RN, MSN, AOCN®, ANP-BC 

Read More
Appendix

Appendix

Lisa Cordes, PharmD, BCACP, BCOP

Read More
Editorial

Priming the Pump Task Force



Read More
Continuing Education

How to Earn Credit



Read More
Copyright © 2010-2018 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.